DYSPHAGIA RESEARCH SOCIETY INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$335,258
Investments
64%
Cash & Equivalents
25%
Prepaid Expenses
11%
Receivables (Non-Related)
0%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$85,357
Deferred Revenue
>99%
Payables & Accruals
<1%
Grants Payable
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$37,163
$82,201
+121%
Receivables (Non-Related)
$8,207
-
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$149,079
$37,950
-75%
Investments
$324,542
$215,107
-34%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$518,991
$335,258
-35%
Liabilities
2023
2024
Change
Payables & Accruals
$41,446
$312
-99%
Grants Payable
-
-
-
Deferred Revenue
$33,445
$85,045
+154%
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$74,891
$85,357
+14%
Net assets
2023
2024
Change
Restricted Net Assets
$15,000
$13,500
-10%
Unrestricted Net Assets
$429,100
$236,401
-45%
Net assets
2023
2024
Change
Net assets
+$444,100
+$249,901
-44%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)